期刊文献+

^(89)Srcl_2对骨转移癌的治疗应用

Application of ^(89)Src1_2 to treat metastasis of the bone in malignancy
下载PDF
导出
摘要 目的探讨89Srcl2对恶性肿瘤骨转移的治疗效果。方法对52例骨转移癌病人两次静脉注射89Srcl2治疗,每次2.2MBq/kg,两次治疗间隔时间为3月。结果第1次治疗骨痛缓解率为69.23%,两次治疗后缓解率为86.54%;第1次89Srcl2治疗后对骨转移癌有效率为26.9%,第2次治疗后有效率为42.3%。结论89Srcl2不仅可以缓解骨转移癌所致的骨痛,而且对转移灶也有一定的治疗作用,连续两次治疗更为有效。 Objective To study the effect of 89 Srcl 2 in treatment of metastasis of the bone in malignancy.Methods 52cases are treated by means of injection of 89 Src1 2 (2.2MBq/kg)twice in a three month interval.Results The effective rat of the bone-pain palliated was69.23%after the first treatment and86.54%after the second treatment.The effective rate of the metastasis of the bone was26.9%after the first treatment and42.3%after the second treatment.Conclusions The 89 Src1 2 b is effective on cancer patients with metastasis and bone pain,and twice treatment is better than single treatment.
出处 《海南医学》 CAS 2005年第1期41-42,共2页 Hainan Medical Journal
关键词 ^89SRCL2 骨转移癌 骨痛 ^(89)Srcl_2 Metastasis of the bone The bone pain
  • 相关文献

参考文献9

  • 1中华人民共和国卫生部医政局.核医学诊断与治疗规范[M].北京:北京科学出版社,1997.292-295.
  • 2陈雪红,钟甘平,王正江,袁耿彪,王家吉,冯建中,李西焕.^(89)SrCl_2对老年人前列腺癌转移性骨痛的疗效观察[J].中华老年医学杂志,2003,22(12):720-722. 被引量:4
  • 3肖国有.^(89)SrCl_2治疗骨转移瘤临床疗效评价[J].广西医学,2004,26(2):191-192. 被引量:5
  • 4冉清,杨光文,陈明曦,潘慈康.^(89)SrCl_2在前列腺癌骨转移治疗中的应用[J].中华泌尿外科杂志,2003,24(6):386-387. 被引量:8
  • 5高晓峰 陈玉每 侯跃军.放射性核素^89Srcl2治疗腺老转移性骨痛的临床应用[J].中华临床医药卫生杂志,2004,2(3):14-15.
  • 6Kvinnsland Y,Bruland O,Moe L,et al.A method for measurement of the uptake patterns of two betaemitting radionuclides in the same tissue section with a digital silicon detector, application to a study of 89Srcl2 and 153Sm-EDTMP in a dog with spontaneous osteosarcoma. Eur J Nucl Med Moll maging.2002Feb,29(2):191-7
  • 7Barysheva EV, Obradovic V, Stefanovic L, et al. Radiologic follow-up and prognosis of efficiency of systemic Sr-89 Cl-2 therapy of bone metastases in prostate cancer. Vestn Rentgenol Radiol. 2000 NovDec,(6):46-50.
  • 8Barysheva EV, Obradovic V, Stefanovie L, et al. Radiologic follow-up and prognosis of efficiency of systemic Sr-89 C1-2 therapy of bone metastases in prostate cancer. Vestn Rentsenol RadioL 2000 NovDec,(6):46-50.
  • 9Kvinmland Y,Bruland O,Moe L,et al.A method for measurement of the uptake patterns of two betaemitting radionuelides in the same tissue section with a digital silicon detector, application to a study of ^89Srcl2 and 153Sm-EDTMP in a dog with spontaneous osteosarcoma. Eur J Nucl Med Moll maging. 2002Feb, 29(2):191-7.

二级参考文献10

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部